{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:54:58Z","timestamp":1790963698794,"version":"4.1.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.neuropharm.2008.07.016","type":"journal-article","created":{"date-parts":[[2008,7,20]],"date-time":"2008-07-20T04:06:00Z","timestamp":1216526760000},"page":"1072-1080","source":"Crossref","is-referenced-by-count":201,"title":["Serotonin and GI clinical disorders"],"prefix":"10.1016","volume":"55","author":[{"given":"Robin","family":"Spiller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2008.07.016_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2005.09.031","article-title":"Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome","volume":"130","author":"Atkinson","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2036.2000.00684.x","article-title":"A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome","volume":"14","author":"Bardhan","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/gut.39.4.528","article-title":"5-hydroxytryptamine release into human jejunum by cholera toxin","volume":"39","author":"Bearcroft","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/gut.42.1.42","article-title":"Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study","volume":"42","author":"Bearcroft","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1053\/j.gastro.2004.04.006","article-title":"Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction","volume":"127","author":"Bercik","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1053\/gast.2002.35990","article-title":"Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist alosetron","volume":"123","author":"Berman","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00712758","article-title":"Increased populations of endocrine cells in Crohn's ileitis","volume":"410","author":"Bishop","year":"1987","journal-title":"Virchows Arch. A Pathol. Anat. Histopathol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib8","first-page":"G498","article-title":"Differential 5-HT3 mediation of human gastrocolonic response and colonic peristaltic reflex","volume":"275","author":"Bjornsson","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1749-6632.1997.tb48183.x","article-title":"Heterogeneity of 5-HT receptors mediating secretion in the human intestine","volume":"812","author":"Borman","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/gut.44.5.682","article-title":"Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans","volume":"44","author":"Bouras","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib11","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1053\/j.gastro.2007.02.036","article-title":"Enterochromaffin cells of\u00a0the\u00a0human gut: sensors for spices and odorants","volume":"132","author":"Braun","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ar.1092330110","article-title":"Renewal of enterochromaffin cells in the rat caecum","volume":"233","author":"de Bruine","year":"1992","journal-title":"Anat. Rec."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.gastro.2006.11.020","article-title":"Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome","volume":"132","author":"Camilleri","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1053\/gast.2002.34780","article-title":"Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome","volume":"123","author":"Camilleri","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib15","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMoa0800670","article-title":"A placebo-controlled trial of prucalopride for severe chronic constipation","volume":"358","author":"Camilleri","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib16","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1046\/j.1365-2036.1999.00610.x","article-title":"Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist","volume":"13","author":"Camilleri","year":"1999","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(00)02033-X","article-title":"Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial","volume":"355","author":"Camilleri","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/gut.24.5.405","article-title":"Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns","volume":"24","author":"Cann","year":"1983","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1258\/000456302760413351","article-title":"Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease","volume":"39","author":"Carling","year":"2002","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2982.2006.00810.x","article-title":"5-HT4 receptor agonists enhance both cholinergic and nitrergic activities in human isolated colon circular muscle","volume":"18","author":"Cellek","year":"2006","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib21","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/gut.18.11.882","article-title":"Increased tissue concentrations of 5-hydroxytryptamine in the duodenal mucosa of patients with coeliac disease","volume":"18","author":"Challacombe","year":"1977","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib22","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1572-0241.2006.00459.x","article-title":"Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: systematic review of clinical trials and post-marketing surveillance data","volume":"101","author":"Chang","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0344-0338(88)80042-6","article-title":"Neuroendocrine tumors of the gastrointestinal tract","volume":"183","author":"Chejfec","year":"1988","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib24","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1651-2227.1997.tb08570.x","article-title":"Platelet serotonin transporter in coeliac disease","volume":"86","author":"Chiaravalloti","year":"1997","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/j.gastro.2004.04.070","article-title":"Endogenous adenosine differentially modulates 5-hydroxytryptamine release from a human enterochromaffin cell model","volume":"127","author":"Christofi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(08)63183-2","article-title":"Opiate induced constipation is not associated with changes in serotonin signaling in the rectal mucosa as observed in ibs and colitis","volume":"134","author":"Coates","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib27","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2004.03.013","article-title":"Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome","volume":"126","author":"Coates","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib28","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cgh.2006.04.017","article-title":"Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease","volume":"4","author":"Coleman","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib29","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1046\/j.1365-2036.2003.01797.x","article-title":"Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans","volume":"18","author":"Coleman","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000070202","article-title":"Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial","volume":"67","author":"Coremans","year":"2003","journal-title":"Digestion"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/bjc.1992.242","article-title":"Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs","volume":"66","author":"Cubeddu","year":"1992","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2982.2007.01059.x","article-title":"5-HT4 receptor agonists: similar but not the same","volume":"20","author":"De Maeyer","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2002.01195.x","article-title":"The effects of the specific 5HT(4) receptor agonist, prucalopride, on colonic motility in healthy volunteers","volume":"16","author":"De Schryver","year":"2002","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib34","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1046\/j.1365-2036.2001.01103.x","article-title":"Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects","volume":"15","author":"Degen","year":"2001","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib35","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-2036.1998.00375.x","article-title":"Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome","volume":"12","author":"Delvaux","year":"1998","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib36","first-page":"E85","article-title":"Effect of serotonin treatment on intestinal transport in the rabbit","volume":"232","author":"Donowitz","year":"1977","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s005200050062","article-title":"The relationship between parameters of serotonin metabolism and emetogenic potential of platinum-based chemotherapy regimens","volume":"5","author":"DuBois","year":"1997","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1542-3565(04)00726-8","article-title":"Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome","volume":"3","author":"Dunlop","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib39","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1053\/j.gastro.2003.09.028","article-title":"Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS","volume":"125","author":"Dunlop","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib40","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2362.1994.tb01058.x","article-title":"Effect of 5-hydroxytryptamine antagonists on cholera toxin-induced secretion in the human jejunum","volume":"24","author":"Eherer","year":"1994","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-2796.1997.00237.x","article-title":"Colonic endocrine cells in inflammatory bowel disease","volume":"242","author":"El Salhy","year":"1997","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003960.pub2","article-title":"Tegaserod for the treatment of irritable bowel syndrome","author":"Evans","year":"2004","journal-title":"Cochrane"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF01297056","article-title":"Intraluminal release of serotonin, substance P, and gastrin in the canine small intestine","volume":"32","author":"Ferrara","year":"1987","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib44","doi-asserted-by":"crossref","first-page":"G779","DOI":"10.1152\/ajpgi.00470.2006","article-title":"IFN-gamma and TNF-alpha decrease serotonin transporter function and expression in CaCO2 cells","volume":"292","author":"Foley","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib45","first-page":"A740","article-title":"Serotonin transporter expression is reduced in celiac disease","volume":"130","author":"Foley","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib46","first-page":"755","article-title":"Regulation of serotonin release from rabbit intestinal enterochromaffin cells","volume":"227","author":"Forsberg","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib47","first-page":"A72","article-title":"Alterations in intestinal serotonin expression in dyspepsia and irritable bowel syndrome","volume":"132","author":"Foxx-Orenstein","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s004180050151","article-title":"Immunoelectron microscopic study of the luminal release of serotonin from rat enterochromaffin cells induced by high intraluminal pressure","volume":"108","author":"Fujimiya","year":"1997","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib49","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2710.2005.00695.x","article-title":"Effect of MKC-733, a 5-HT receptor partial agonist, on bowel motility and symptoms in subjects with constipation: an exploratory study","volume":"30","author":"Fujita","year":"2005","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib50","doi-asserted-by":"crossref","first-page":"R1269","DOI":"10.1152\/ajpregu.00442.2002","article-title":"Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats","volume":"284","author":"Fukumoto","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2008.07.016_bib51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2036.1999.00002.x-i2","article-title":"Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel","volume":"13","author":"Gershon","year":"1999","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib52","doi-asserted-by":"crossref","first-page":"G254","DOI":"10.1152\/ajpgi.00354.2007","article-title":"Function, expression, and characterization of the serotonin transporter in the native human intestine","volume":"294","author":"Gill","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.0.CO;2-0","article-title":"Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets","volume":"88","author":"Greenberg","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib54","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0016-5085(98)70203-3","article-title":"5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine","volume":"115","author":"Grider","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib55","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1099\/00222615-47-2-151","article-title":"Secretory pathways in Salmonella typhimurium-induced fluid accumulation in the porcine small intestine","volume":"47","author":"Grondahl","year":"1998","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib56","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/jsre.1994.1044","article-title":"5-HT receptor subtypes involved in luminal serotonin-induced secretion in rat intestine in vivo","volume":"56","author":"Hansen","year":"1994","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1113\/expphysiol.1988.sp003124","article-title":"The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret","volume":"73","author":"Hawthorn","year":"1988","journal-title":"Q. J. Exp. Physiol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib58","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1200\/JCO.2003.01.095","article-title":"The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin\u2013the aprepitant protocol 052 study group","volume":"21","author":"Hesketh","year":"2003","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10787-006-1537-1","article-title":"Pharmacological profile of ramosetron, a novel therapeutic agent for IBS","volume":"15","author":"Hirata","year":"2007","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib60","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2036.2000.00762.x","article-title":"Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers","volume":"14","author":"Houghton","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib61","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/gut.36.4.585","article-title":"Scintigraphic measurement of ileocaecal transit in irritable bowel syndrome and chronic idiopathic constipation","volume":"36","author":"Hutchinson","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib62","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1046\/j.1365-2036.1999.00678.x","article-title":"Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients","volume":"13","author":"Jones","year":"1999","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib63","first-page":"G515","article-title":"Stroking human jejunal mucosa induces 5-HT release and Cl- secretion via afferent neurons and 5-HT4 receptors","volume":"277","author":"Kellum","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib64","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2982.2008.01100.x","article-title":"Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients","author":"Kerckhoffs","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib65","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1677\/jme.1.02037","article-title":"Further delineation of the continuous human neoplastic enterochromaffin cell line, KRJ-I, and the inhibitory effects of lanreotide and rapamycin","volume":"38","author":"Kidd","year":"2007","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib66","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2982.2007.00912.x","article-title":"Mechanically evoked 5-hydroxytryptamine release is mediated by caveolin-associated cholesterol rich membrane domains","volume":"19","author":"Kim","year":"2007","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib67","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1172\/JCI12467","article-title":"Mechanical stimulation activates Galphaq signaling pathways and 5-hydroxytryptamine release from human carcinoid BON cells","volume":"108","author":"Kim","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib68","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/gut.2003.033563","article-title":"Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea","volume":"53","author":"Kordasti","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib69","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0022-4804(87)90156-9","article-title":"Serotonin release is mediated by muscarinic receptors on duodenal mucosal cells","volume":"43","author":"Kuemmerle","year":"1987","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib70","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/0022-4804(88)90109-6","article-title":"Beta-adrenoceptors on duodenal mucosal cells mediate venous serotonin release","volume":"44","author":"Kuemmerle","year":"1988","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib71","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/00365527709180942","article-title":"Rectal mucosal adrenergic innervation and enterochromaffin cells in ulcerative colitis and irritable colon","volume":"12","author":"Kyosola","year":"1977","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib72","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2982.2005.00621.x","article-title":"5-HT4 receptors located on cholinergic nerves in human colon circular muscle","volume":"17","author":"Leclere","year":"2005","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib73","doi-asserted-by":"crossref","first-page":"G207","DOI":"10.1152\/ajpgi.00488.2002","article-title":"Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis","volume":"285","author":"Linden","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib74","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2982.2005.00673.x","article-title":"Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis","volume":"17","author":"Linden","year":"2005","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib75","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/jpet.107.132670","article-title":"Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract","volume":"325","author":"Liu","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib76","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1042\/cs0940663","article-title":"Concentration-dependent stimulation of intestinal phase III of migrating motor complex by circulating serotonin in humans","volume":"94","author":"Lordal","year":"1998","journal-title":"Clin. Sci. (Colch.)"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib77","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1042\/CS19980040","article-title":"Characteristics of small bowel motility in patients with irritable bowel syndrome and normal humans: an Oriental study","volume":"95","author":"Lu","year":"1998","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib78","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1023\/A:1013256629600","article-title":"Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease","volume":"47","author":"Magro","year":"2002","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib79","first-page":"83","article-title":"Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods","volume":"60","author":"Mahesh","year":"2005","journal-title":"Pharmazie"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib80","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2036.1996.30172000.x","article-title":"Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?","volume":"10","author":"Maxton","year":"1996","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib81","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0306-3623(97)00095-5","article-title":"Investigation into the effect of 5-hydroxytryptamine on fluid transport in the rat small intestine","volume":"30","author":"McLean","year":"1998","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib82","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cgh.2007.02.013","article-title":"Serotonin synthesis and uptake in symptomatic patients with Crohn's disease in remission","volume":"5","author":"Minderhoud","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib83","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000051888","article-title":"Patients with constipation-predominant irritable bowel syndrome (ibs) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits","volume":"63","author":"Miwa","year":"2001","journal-title":"Digestion"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib84","first-page":"G1001","article-title":"Role of 5-HT in cholera toxin-induced mucin secretion in the rat small intestine","volume":"270","author":"Moore","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib85","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/gut.2007.129296","article-title":"Enterochromaffin cell and 5-hydroxytryptamine responses to the same infectious agent differ in Th1 and Th2 dominant environments","volume":"57","author":"Motomura","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib86","first-page":"419","article-title":"Gastrointestinal endocrine cell hyperplasia in celiac disease: a selective proliferative process of serotonergic cells","volume":"4","author":"Moyana","year":"1991","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib87","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1046\/j.1365-2036.2001.01094.x","article-title":"Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation","volume":"15","author":"Muller-Lissner","year":"2001","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib88","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1113\/jphysiol.1993.sp019895","article-title":"Role of 5-HT3 receptors in peristaltic reflex elicited by stroking the mucosa in the canine jejunum","volume":"471","author":"Neya","year":"1993","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib89","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1046\/j.1365-2036.2002.01372.x","article-title":"A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation","volume":"16","author":"Novick","year":"2002","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib90","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1462-5822.2005.00657.x","article-title":"Consequences of Citrobacter rodentium infection on enteroendocrine cells and the enteric nervous system in the mouse colon","volume":"8","author":"O'Hara","year":"2006","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib91","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s004180050445","article-title":"Changes in number of serotonin-containing cells and serotonin levels in the intestinal mucosa of rats with colitis induced by dextran sodium sulfate","volume":"112","author":"Oshima","year":"1999","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib92","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/0016-5085(94)90008-6","article-title":"A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea","volume":"106","author":"von der Ohe","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib93","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJM199310073291503","article-title":"Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea","volume":"329","author":"von der Ohe","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib94","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/gut.35.4.536","article-title":"Serotonergic mediation of postprandial colonic tonic and phasic responses in humans","volume":"35","author":"von der Ohe","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib95","first-page":"127","article-title":"Intestinal endocrine cells in radiation enteritis","volume":"169","author":"Pietroletti","year":"1989","journal-title":"Surg. Gynecol. Obstet."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib96","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0016-5085(00)70251-4","article-title":"Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome","volume":"118","author":"Prather","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib97","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2036.1993.tb00087.x","article-title":"Reduction of rectal sensitivity and post-prandial motility by granisetron, a 5 HT3-receptor antagonist, in patients with irritable bowel syndrome","volume":"7","author":"Prior","year":"1993","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1523\/JNEUROSCI.17-01-00045.1997","article-title":"Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression","volume":"17","author":"Qian","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib99","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/acta.0.1240203","article-title":"Evidence that neuronally released vasoactive intestinal polypeptide inhibits the release of serotonin from enterochromaffin cells of the guinea pig small intestine","volume":"124","author":"Racke","year":"1991","journal-title":"Acta Endocrinol. (Copenh)"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib100","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1126\/science.285.5428.763","article-title":"Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants","volume":"285","author":"Ramamoorthy","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib101","first-page":"A3","article-title":"Identification and diagnosis of patients with irritable bowel syndrome in primary care: nominal group technique","volume":"54","author":"Rubin","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib102","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000082875","article-title":"Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide","volume":"80","author":"Ruszniewski","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib103","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(01)06581-3","article-title":"Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care","volume":"358","author":"Sanders","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib104","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/gut.42.5.628","article-title":"Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea","volume":"42","author":"Saslow","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0014-2999(89)90767-X","article-title":"GABA receptors are involved in the modulation of the release of 5-hydroxytryptamine from the vascularly perfused small intestine of the guinea-pig","volume":"165","author":"Schworer","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib106","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/jsre.1993.1149","article-title":"A 5-HT2 receptor mediates serotonin-induced electrolyte transport in rat left colon","volume":"55","author":"Siriwardena","year":"1993","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib107","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/00365528509091655","article-title":"Increased levels of plasma 5-hydroxytryptamine in patients with coeliac disease","volume":"20","author":"Sjolund","year":"1985","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib108","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0016-5085(83)80080-8","article-title":"Endocrine cells in human intestine: an immunocytochemical study","volume":"85","author":"Sjolund","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib109","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0016-5085(03)00324-X","article-title":"Postinfectious irritable bowel syndrome","volume":"124","author":"Spiller","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib110","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0016-5085(82)90312-2","article-title":"The role of opiate receptors and cholinergic neurons in the gastrocolonic response","volume":"82","author":"Sun","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib111","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF01536922","article-title":"GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man","volume":"35","author":"Talley","year":"1990","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib112","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sj.bjp.0703414","article-title":"The inhibition of cholera toxin-induced 5-HT release by the 5-HT(3) receptor antagonist, granisetron, in the rat","volume":"130","author":"Turvill","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib113","doi-asserted-by":"crossref","DOI":"10.1136\/gut.2006.103226","article-title":"CD4+T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection","author":"Wang","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib114","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1365-2249.2002.01798.x","article-title":"Inflammatory cytokines in small intestinal mucosa of patients with potential coeliac disease","volume":"128","author":"Westerholm-Ormio","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib115","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2982.2005.00719.x","article-title":"Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction","volume":"17","author":"Wheatcroft","year":"2005","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib116","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/adc.59.6.523","article-title":"Quantification of enterochromaffin cells with serotonin immunoreactivity in the duodenal mucosa in coeliac disease","volume":"59","author":"Wheeler","year":"1984","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.neuropharm.2008.07.016_bib117","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/0016-5085(88)90005-4","article-title":"Participation of gastric mechanoreceptors and intestinal chemoreceptors in the gastrocolonic response","volume":"94","author":"Wiley","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib118","first-page":"86","article-title":"Serotonin and substance P stimulate intestinal secretion in the isolated perfused ileum","volume":"105","author":"Yeo","year":"1989","journal-title":"Surgery"},{"key":"10.1016\/j.neuropharm.2008.07.016_bib119","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/BF02064986","article-title":"Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism","volume":"40","author":"Zighelboim","year":"1995","journal-title":"Dig. Dis. Sci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808002906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808002906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T08:24:06Z","timestamp":1631521446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390808002906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":119,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0028390808002906"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2008.07.016","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}